bromodeoxyuridine has been researched along with Corneal Neovascularization in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Chopp, M; Jiang, H; Kapke, A; Li, Y; Lu, M; Roberts, C; Zacharek, A; Zhang, C | 1 |
Bachmann, B; Bock, F; Cursiefen, C; Dietrich, T; Kruse, FE; Onderka, J; Paschke, M; Zahn, G | 1 |
Beecken, WD; Joussen, AM; Kirchhof, B; Moromizato, Y; Poulaki, V; Schwartz, A | 1 |
3 other study(ies) available for bromodeoxyuridine and Corneal Neovascularization
Article | Year |
---|---|
Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice.
Topics: Animals; Blood Pressure; Brain; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Count; Cell Movement; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Doublecortin Domain Proteins; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Gene Expression; Immunohistochemistry; Infarction, Middle Cerebral Artery; Intermediate Filament Proteins; Ki-67 Antigen; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Naphthalenes; Nerve Tissue Proteins; Nestin; Neurites; Neurologic Examination; Neuropeptides; Nitric Oxide Synthase Type III; Oxepins; Psychomotor Performance; Recovery of Function; Telomerase; Time Factors; Vascular Endothelial Growth Factor A | 2005 |
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Blotting, Western; Bromodeoxyuridine; Cell Proliferation; Corneal Neovascularization; Disease Models, Animal; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Glycoproteins; Lymphangiogenesis; Membrane Transport Proteins; Mice; Mice, Inbred BALB C; Platelet Endothelial Cell Adhesion Molecule-1; Surface Plasmon Resonance; Vascular Endothelial Growth Factor A | 2007 |
Inhibition of inflammatory corneal angiogenesis by TNP-470.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Bromodeoxyuridine; Cell Division; Corneal Neovascularization; Cyclohexanes; DNA Replication; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Corneal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Injections, Subcutaneous; Lymphokines; Mice; Mice, Inbred C57BL; O-(Chloroacetylcarbamoyl)fumagillol; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |